Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Jia-Min B Pang"'
Autor:
Jia-Min B Pang, David J Byrne, Elena A Takano, Nicholas Jene, Lara Petelin, Joanne McKinley, Catherine Poliness, Christobel Saunders, Donna Taylor, Gillian Mitchell, Stephen B Fox
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0128861 (2015)
AIM:To investigate the cellular and immunophenotypic basis of mammographic density in women at high risk of breast cancer. METHODS:Mammograms and targeted breast biopsies were accrued from 24 women at high risk of breast cancer. Mammographic density
Externí odkaz:
https://doaj.org/article/1c5d0674cbf6446ca55a88e9b590046b
Autor:
Erica K. Sloan, Bernhard Riedel, Stephen Fox, Paul S. Myles, Kwok M. Ho, Sophie S. Nightingale, Michael A. Henderson, Jia-Min B. Pang, David M. Shackleford, David J. Byrne, Elizabeth M. Crone, Steven W. Cole, Jonathan G. Hiller
Purpose:The majority of deaths from breast cancer occur following the development of metastatic disease, a process inhibited by β-blockers in preclinical studies. This phase II randomized controlled trial evaluated the effect of preoperative β-bloc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a87af828cdf3b93ecf66e7e4ebbd2e4f
https://doi.org/10.1158/1078-0432.c.6529944.v1
https://doi.org/10.1158/1078-0432.c.6529944.v1
Autor:
Erica K. Sloan, Bernhard Riedel, Stephen Fox, Paul S. Myles, Kwok M. Ho, Sophie S. Nightingale, Michael A. Henderson, Jia-Min B. Pang, David M. Shackleford, David J. Byrne, Elizabeth M. Crone, Steven W. Cole, Jonathan G. Hiller
Supplementary Material
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c540875173420af39c71b0ba227a6d2
https://doi.org/10.1158/1078-0432.22478397.v1
https://doi.org/10.1158/1078-0432.22478397.v1
Autor:
Stephen B. Fox, Kylie L. Gorringe, G. Bruce Mann, Ian G. Campbell, Margaret C. Cummings, Sunil R. Lakhani, David J. Byrne, Jia-Min B. Pang, Shona Hendry
Supplementary Figure Legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d6224ef20c44c3c62fee35208a1cf5f
https://doi.org/10.1158/1078-0432.22466037.v1
https://doi.org/10.1158/1078-0432.22466037.v1
Autor:
Stephen B. Fox, Kylie L. Gorringe, G. Bruce Mann, Ian G. Campbell, Margaret C. Cummings, Sunil R. Lakhani, David J. Byrne, Jia-Min B. Pang, Shona Hendry
Purpose: The immune microenvironment of breast ductal carcinoma in situ (DCIS) has yet to be fully explored, and the relationship of immune cells to genetic features of DCIS is unknown.Experimental Design: We quantified tumor associated lymphocytes (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aff2ffac6c3c38639ae47ea02e90ef8
https://doi.org/10.1158/1078-0432.c.6526224.v1
https://doi.org/10.1158/1078-0432.c.6526224.v1
Autor:
Stephen B. Fox, Kylie L. Gorringe, G. Bruce Mann, Ian G. Campbell, Margaret C. Cummings, Sunil R. Lakhani, David J. Byrne, Jia-Min B. Pang, Shona Hendry
Figures S1 and S2, Tables S1 and S2 Supplementary Information Supplementary Table 1. DCIS cases assessed for tumour lymphocytes Supplementary Table 2. DCIS cases assessed for PD-L1 protein expression Supplementary Figure 1. Cohort summary Supplementa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c893ebd7f0e6280b6b98ad790c26d702
https://doi.org/10.1158/1078-0432.22466034.v1
https://doi.org/10.1158/1078-0432.22466034.v1
Publikováno v:
ANZ Journal of Surgery. 92:3366-3368
Autor:
Beena Kumar, David Clouston, Kate Harvey, Jia-Min B Pang, Jane Beith, Jane E. Armes, Sunil R. Lakhani, Shona Hendry, Christina I. Selinger, Stephen B. Fox, Charles Chan, Wendy A. Raymond, Wendy A Cooper, Samuel Roberts-Thomson, Marian L. Burr, Peter Button, David J Byrne, Sandra A O'Toole, Ewan K.A. Millar, Vanathi Sivasubramaniam, Belinda Castles
Publikováno v:
The American Journal of Surgical Pathology
Supplemental Digital Content is available in the text.
SP142 programmed cell death ligand 1 (PD-L1) status predicts response to atezolizumab in triple-negative breast carcinoma (TNBC). Prevalence of VENTANA PD-L1 (SP142) Assay positivity, concor
SP142 programmed cell death ligand 1 (PD-L1) status predicts response to atezolizumab in triple-negative breast carcinoma (TNBC). Prevalence of VENTANA PD-L1 (SP142) Assay positivity, concor
Autor:
Jia-Min B Pang, G. Bruce Mann, Ian G. Campbell, Margaret C. Cummings, David J Byrne, Stephen B. Fox, Kylie L. Gorringe, Sunil R. Lakhani, Shona Hendry
Publikováno v:
Clinical Cancer Research. 23:5210-5217
Purpose: The immune microenvironment of breast ductal carcinoma in situ (DCIS) has yet to be fully explored, and the relationship of immune cells to genetic features of DCIS is unknown. Experimental Design: We quantified tumor associated lymphocytes
Autor:
Kevin Christopher Knower, Elena A Takano, Alexander Dobrovic, Stephen B. Fox, Kylie L. Gorringe, Ramyar Molania, David J Byrne, Sandra A O'Toole, Ewan K.A. Millar, Ashwini L. Chand, Jia Min B. Pang, Colin Clyne, Cheok Soon Lee, Thomas Mikeska
Publikováno v:
Oncotarget
The significance and regulation of liver receptor homologue 1 (LRH-1, NR5A2), a tumour-promoting transcription factor in breast cancer cell lines, is unknown in clinical breast cancers. This study aims to determine LRH-1/NR5A2 expression in breast ca